- Filed
- Apr 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 9, 2025 | 229.16M sh |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $685.01K |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $849.73K |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.43M |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $1.5M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.1M |
| Current Assets | Q1 2025 · Sep 30, 2024 | $1.2M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.18M |
| Total Assets | Q1 2025 · Sep 30, 2024 | $1.3M |
| Shares Diluted | Q1 2025 · Dec 31, 2023 | 599.48M sh |
| Operating Cash Flow | Q1 2025 · Dec 31, 2023 | $378.59K |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $22.84K |
| Stockholders Equity | Q1 2025 · Sep 30, 2023 | $5.18K |
| Eps Diluted | Q1 2025 · Dec 31, 2023 | $0.00 |
| Eps Basic | Q1 2025 · Dec 31, 2023 | $0.00 |
| Sga Expense | Q1 2025 · Dec 31, 2023 | $406K |
| Rd Expense | Q1 2025 · Dec 31, 2023 | $13.56K |
| Net Income | Q1 2025 · Dec 31, 2023 | $17.67K |
| Gross Profit restated | Q1 2025 · Dec 31, 2023 | $487.15K |
| Cost Of Revenue restated | Q1 2025 · Dec 31, 2023 | $118.9K |
| Revenue | Q1 2025 · Dec 31, 2023 | $606.05K |